Neurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, marking the neuroscience-focused drugmaker’s expansion into metabolic disorders.Read More
Goldman Sachs’ private credit fund disclosed on Monday that investors sought to repurchase just under 5% of shares in the first quarter, setting it apart from the rest of the industry that is struggling with a surge in redemptions.Read More
The S&P 500 and the Nasdaq opened higher on Monday after the indexes marked their biggest weekly jump in four months in the last session, while investors assessed prospects of an end to the Middle East conflict.Read More
Indian bonds surged on Monday, with the 10-year yield falling the most in nearly 15 weeks, on hopes of an end to the Middle East war after the U.S. and Iran received the framework for a plan to end their five-week-old conflict.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
